YS Biopharma Valuation

YS Stock   0.94  0.09  10.59%   
Today, the company appears to be overvalued. YS Biopharma owns a latest Real Value of USD0.67 per share. The recent price of the company is USD0.94. Our model calculates the value of YS Biopharma from evaluating the company fundamentals such as number of shares shorted of 96.84 K, and Return On Asset of -0.12 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage acquiring undervalued equities and selling overvalued equities since, at some future date, asset prices and their ongoing real values will blend. Key fundamental drivers impacting YS Biopharma's valuation include:
Price Book
Enterprise Value
373.7 M
Enterprise Value Ebitda
Price Sales
Enterprise Value Revenue
Please note that YS Biopharma's price fluctuation is out of control at this time. Calculation of the real value of YS Biopharma is based on 3 months time horizon. Increasing YS Biopharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for YS Biopharma Co is useful when determining the fair value of the YS Biopharma stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of YS Biopharma. Since YS Biopharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of YS Biopharma Stock. However, YS Biopharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.94 Real  0.67 Target  5.1 Hype  0.94 Naive  0.97
The real value of YS Biopharma Stock, also known as its intrinsic value, is the underlying worth of YS Biopharma Company, which is reflected in its stock price. It is based on YS Biopharma's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of YS Biopharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence YS Biopharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Real Value
Estimating the potential upside or downside of YS Biopharma Co helps investors to forecast how YS Biopharma stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of YS Biopharma more accurately as focusing exclusively on YS Biopharma's fundamentals will not take into account other important factors:
Estimates (0)
LowNext ValueHigh
1 Analysts
LowTarget PriceHigh
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use YS Biopharma's intrinsic value based on its ongoing forecasts of YS Biopharma's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against YS Biopharma's closest peers. When choosing an evaluation method for YS Biopharma, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

YS Biopharma Investments

(68.81 Million)

YS Biopharma Valuation Trend

Knowing YS Biopharma's actual value is paramount for traders to make sound investment determinations. YS Biopharma's real value is not only important for the investor to make better decisions but also for a more accurate overall view of YS Biopharma's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both YS Biopharma's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

YS Biopharma Market Cap

YS Biopharma Co is rated first in market capitalization category among related companies. Market capitalization of Health Care industry is at this time estimated at about 45.02 Billion. YS Biopharma adds roughly 167.91 Million in market capitalization claiming only tiny portion of equities under Health Care industry.
Capitalization  Revenue  Valuation  Workforce  Total debt

YS Biopharma Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining YS Biopharma's current stock value. Our valuation model uses many indicators to compare YS Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across YS Biopharma competition to find correlations between indicators driving YS Biopharma's intrinsic value. More Info.
YS Biopharma Co is rated first in price to book category among related companies. It is rated first in price to sales category among related companies fabricating about  0.14  of Price To Sales per Price To Book. The ratio of Price To Book to Price To Sales for YS Biopharma Co is roughly  7.27 . At this time, YS Biopharma's Price To Sales Ratio is comparatively stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value YS Biopharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for YS Biopharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the YS Biopharma's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates YS Biopharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in YS Biopharma and how it compares across the competition.

About YS Biopharma Valuation

The stock valuation mechanism determines the current worth of YS Biopharma Co on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of YS Biopharma Co. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of YS Biopharma based exclusively on its fundamental and basic technical indicators. By analyzing YS Biopharma's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of YS Biopharma's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of YS Biopharma. We calculate exposure to YS Biopharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to YS Biopharma's related companies.
Last ReportedProjected for Next Year
Gross Profit613.9 M409.6 M
Pretax Profit Margin(0.19)(0.20)
Operating Profit Margin(0.18)(0.19)
Net Loss(0.19)(0.20)
Gross Profit Margin 0.70  0.62 

8 Steps to conduct YS Biopharma's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates YS Biopharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct YS Biopharma's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain YS Biopharma's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine YS Biopharma's revenue streams: Identify YS Biopharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research YS Biopharma's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish YS Biopharma's growth potential: Evaluate YS Biopharma's management, business model, and growth potential.
  • Determine YS Biopharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate YS Biopharma's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

YS Biopharma Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as YS Biopharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding93.1 M

YS Biopharma Current Valuation Indicators

Valuation refers to the process of determining the present value of YS Biopharma Co and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value YS Biopharma we look at many different elements of the entity such as YS Biopharma's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. YS Biopharma's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final YS Biopharma's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as YS Biopharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use YS Biopharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes YS Biopharma's worth.
When determining whether YS Biopharma is a strong investment it is important to analyze YS Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact YS Biopharma's future performance. For an informed investment choice regarding YS Biopharma Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in YS Biopharma Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for YS Biopharma Stock analysis

When running YS Biopharma's price analysis, check to measure YS Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy YS Biopharma is operating at the current time. Most of YS Biopharma's value examination focuses on studying past and present price action to predict the probability of YS Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move YS Biopharma's price. Additionally, you may evaluate how the addition of YS Biopharma to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Is YS Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of YS Biopharma. If investors know YS Biopharma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about YS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of YS Biopharma is measured differently than its book value, which is the value of YS Biopharma that is recorded on the company's balance sheet. Investors also form their own opinion of YS Biopharma's value that differs from its market value or its book value, called intrinsic value, which is YS Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because YS Biopharma's market value can be influenced by many factors that don't directly affect YS Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between YS Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if YS Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, YS Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.